1-855-378-42281-855-378-4228
One of the outpatient treatment alternatives for individuals in Suncook struggling with opioid dependence and addiction is called opioid maintenance therapy. Licensed centers and doctors are authorized to administer certain meds to opioid addicted individuals, many of which are opioid-based themselves and are habit forming. In low enough amounts the client does not experience being high but also does not experience acute cravings and is not in opioid withdrawal. Methadone is the first medication administered for this sole purpose, but there are a few more choices to pick from.
Methadone is an opiate and can be taken at an outpatient medical center licensed to administer the drug, which is taken on a daily basis as a pill or liquid. The cost of the med is about one hundred and fifty dolloars a month. Buprenorphine is also an opioid-based drug, and is in pill form often taken every other day. But unlike Methadone that is only be dispensed in highly well-regulated clinics, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is approximately just under $300 per month for the generic of the med. There is also a version of buprenorphine that contains naloxone, that is a drug which reverses the effects of opiates. An individual consuming this formulation, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It too is taken daily, and is priced approximately $450 a month. Naltrexone is an additional medication used in opioid maintenance therapy, but unlike the other drugs mentioned it's an opiate blocker and is not an opioid. There is an option to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents someone from getting high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 per month.
For All Alcohol and Drug Treatment Centers In Suncook, Click Here.
